Dermatology-specific and all-cause 30-day and calendar-year readmissions and costs for dermatologic diseases from 2010 to 2014 Journal Article
| Authors: | Zhang, M.; Markova, A.; Harp, J.; Dusza, S.; Rosenbach, M.; Kaffenberger, B. H. |
| Article Title: | Dermatology-specific and all-cause 30-day and calendar-year readmissions and costs for dermatologic diseases from 2010 to 2014 |
| Abstract: | Background: Readmissions for skin disease, particularly for the same diagnosis and over time, have not been well studied. Objective: To characterize hospital readmissions for skin disease. Methods: A cross-sectional observational study examined the Nationwide Readmissions Database from 2010 to 2014, a national sample of hospital discharges in the United States. Results: Of the patients in 3,602,599 dermatologic hospitalizations from 2010 to 2014, 9.8% were readmitted for any cause, 3.3% were admitted for the same diagnosis within 30 days, and 7.8% were readmitted for the same diagnosis within the calendar year (CY). The cost of all CY same-cause readmissions was $508 million per year. Mycosis fungoides had the highest 30-day all-cause readmission rate (32%), vascular hamartomas and dermatomyositis had the highest 30-day same-cause readmission rates (21% and 18%, respectively), and dermatomyositis and systemic lupus erythematosus had the highest CY same-cause readmission rates (31% and 24%, respectively). Readmission rates stayed stable from 2010 to 2014. Readmission for the same diagnosis was strongly associated with Medicaid and morbid obesity. Limitations: This study is a broad description of hospitalizations for skin disease. Conclusions for individual diseases are not intended. Conclusion: The rates and costs of readmissions for skin diseases remained high from 2010 to 2014. This study identifies diseases associated with high risk of hospital readmission, but disease-specific studies are needed. The diseases and risk factors presented should guide additional studies focused on strategies to reduce readmissions in specific skin diseases. © 2019 American Academy of Dermatology, Inc. |
| Keywords: | adolescent; adult; child; aged; middle aged; major clinical study; united states; health care cost; medicaid; hospitalization; infant; newborn; comorbidity; graft versus host reaction; hospital discharge; cross-sectional study; dermatomyositis; skin disease; systemic lupus erythematosus; hospital readmission; epidemiology; observational study; thrombotic thrombocytopenic purpura; dermatology; mycosis fungoides; hamartoma; cellulitis; sezary syndrome; morbid obesity; very elderly; human; male; female; priority journal; article; cost of care; dermatology hospitalizations; dermatology readmissions; hospital readmissions; inpatient dermatology; nationwide readmissions database; vascular hamartoma |
| Journal Title: | Journal of the American Academy of Dermatology |
| Volume: | 81 |
| Issue: | 3 |
| ISSN: | 0190-9622 |
| Publisher: | Mosby Elsevier |
| Date Published: | 2019-09-01 |
| Start Page: | 740 |
| End Page: | 748 |
| Language: | English |
| DOI: | 10.1016/j.jaad.2019.05.023 |
| PUBMED: | 31102603 |
| PROVIDER: | scopus |
| PMCID: | PMC6698216 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 30 August 2019 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work